Select Medical entered into Amendment No. 12 to its existing Credit Agreement, establishing a new $1.0 billion incremental term loan. The amendment, with JPMorgan Chase Bank as administrative and collateral agent and a syndicate of lenders, adds significant debt capacity under the company's long-standing facility. The financing is expected to support the company's go-private transaction and bolster liquidity for ongoing needs.

Agreement details:

  • Agreement type: Amendment adding $1.0 billion incremental term loan to existing credit agreement
  • Counterparty: JPMorgan Chase Bank, as administrative and collateral agent, and other lenders
  • Signed / Effective: Jun 30 2026 / same
  • Reason: Support merger financing and enhance liquidity

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.